ATLASSilexion Therapeutics (SLXN) earnings date: Nov 11, 2026
Silexion Therapeutics (SLXN) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SLXN
| Last price | $0.15 (+3.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±8.8% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Silexion Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Silexion Therapeutics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Silexion Therapeutics. You can switch it off at any time.
Alert me before SLXN reportsFree to start. Creating an account takes under a minute.
Notify me when Silexion Therapeutics reports
Track SLXN free Add Silexion Therapeutics to a free ATLAS watchlist and see its next report date in one place.
SLXN earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 14, 2026 · Miss |
| Beat rate (last 3 reports) | 1 of 3 (33%) |
| Average EPS surprise | -39.4% |
| Average move around a report | ±20.5% (last 3) |
| Sector | Healthcare · Biotechnology |
Silexion Therapeutics earnings history: last 3 reports
Silexion Therapeutics last reported on Aug 14, 2026: EPS of -$5.17 against an estimate of -$2.12 (-143.9% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$2.12 | -$5.17 | -143.9% | Miss | -8.3% |
| Jul 28, 2026 | $2.80 | $2.84 | +1.4% | In line | -36.8% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | +16.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SLXN
See the fair value, the probability range and the earnings history of Silexion Therapeutics on its ATLAS page.
Silexion Therapeutics (SLXN) stock analysisPlans from €3.99 a month.
Silexion Therapeutics earnings: frequently asked questions
When does Silexion Therapeutics (SLXN) report earnings?
Silexion Therapeutics is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does SLXN beat earnings estimates?
Of its last 3 reports with a recorded result, Silexion Therapeutics beat the EPS estimate 1 times; the average surprise was -39.4%. Past results do not predict the next one.
How much does SLXN move around earnings?
Over its last 3 reports the stock moved an average of 20.5% (absolute, from the close before the report day to the close after it), and finished higher 1 of 3 times.
Did Silexion Therapeutics beat earnings estimates last quarter?
Silexion Therapeutics last reported on Aug 14, 2026: EPS of -$5.17 against an estimate of -$2.12 (-143.9% surprise), a miss.
How much does SLXN usually move in a day?
On a normal trading day the ATLAS model puts SLXN’s one-day range at about ±8.8%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer